Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
No symptoms or side effects were reported; patient received a dose of improperly stored VARIVAX; This spontaneous report was received from a healthcare professional and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 16-Jun-2025, the patient was vaccinated with a dose of improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (0.5ml, lot #Y019318, expiration date: 21-Nov-2026; route of administration, dose number in series and anatomical site were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent(MERCK STERILE DILUENT). The temperature excursion was 52.2 Fahrenheit degrees for unknown duration. The healthcare professional reported that she did not know the date the excursion occurred, but knows the Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) was administered following the excursion. There was no previous temperature excursion. No adverse effects reported.
Sterile Diluent